Siltartoxatug

斯泰度塔单抗

Report date: 2025/02/17 09:20:12

Base Information

Drug NameSiltartoxatug
Drug Alias Name新替妥TNM-002TNM002
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionTetanus toxin inhibitors
TargetsTetanus toxin
Therapy Area/IndicationsTetanus
Global Approved IndicationsTetanus
Approved Indications in ChinaTetanus
Original Approved Country/TerritoryMainland China
Original Approved Date2025/02/11
Country/TerritoryUnited StatesAustraliaMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesZhuhai Trinomab Pharmaceutical Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesZhuhai Trinomab Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsTetanus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A